BioLife

BioLife will increase the visible value of Bioscience resources worldwide by combining 3 automated systems for messaging, transaction processing and smart contracts into a digital ecosystem for the Bioscience industry.

BioLife  will  build  a  global  high-end  biomedical  resources  DLT platform  for  products,  services  and  data  to  provide  safe, private, reliable,  efficient  and  economical  service access  for biomedical  resource  owners,  patients  and  investors.

A  consortium  chain  based  on  ACChain,  BioLife  is  an  on-chain asset  digitization  and  private  handler  for  patients,  investors and owners  of  global  biomedical  resources.  BioLife’s  digital ecosystem  is  a  distributed,  adaptive,  open-source,  peer  to peer  system.  Its blockchain  properties  of  self-organization, scalability,  interoperability  and  resilience  were  inspired by  the  very  natural  ecosystems from  which  Swiss  Serolab derives  its  health  care  solutions.  Distribution,  circulation and  service  placement  are  the  three  basic applications  of the  BioLife  digital  ecosystem.

The BioLife Service Platform will provide digital portals for pharmaceutical companies, biomedical institutions and equipment manufacturers and use blockchain technology to record the entire process of the biomedical services supply chain, treatment processes and results. BioLife’s adoption of DLT as its technology backbone will introduce the following benefits to all areas of the biomedical services sector that are impacted by BioLife Data: heightened security and resistance to tampering, protection of personally identifiable information and other elements of privacy (including protection against data scrapes), elimination of any single point of failure and disintermediation of third parties (thereby reducing transaction times and eliminating third party transaction fees).